AD

Gefitinib-d(CAS: 857091-32-8)

Gefitinib-d
CAS Number

Related Products

Other Suppliers for Gefitinib-d

Basic Information

Molecular Formula
C22H16ClD8FN4O3
Molecular Weight
454.95 g/mol

Chemical Identifiers

SMILES
COc1cc2ncnc(c2cc1OCCCN1C([2H])([2H])C([2H])([2H])OC(C1([2H])[2H])([2H])[2H])Nc1ccc(c(c1)Cl)F
InChIKey
XGALLCVXEZPNRQ-IHGLQNJRSA-N

Database References

MDL Number
MFCD30748179

FAQ

Gefitinib-d (CAS: 857091-32-8) is a quinazoline derivative with antineoplastic properties, primarily used in the treatment of non-small cell lung cancer. It inhibits epidermal growth factor receptor (EGFR) tyrosine kinase activity.
Gefitinib-d (CAS: 857091-32-8) is mainly used in the treatment of non-small cell lung cancer in patients who have failed first-line chemotherapy and have mutations in the epidermal growth factor receptor (EGFR). It is also used in clinical trials for other types of cancer.
Gefitinib-d (CAS: 857091-32-8) is generally considered safe when used as prescribed. However, it can cause side effects such as skin rash, diarrhea, and liver toxicity. Patients should be monitored closely for adverse reactions and appropriate protective measures should be taken.
Gefitinib-d (CAS: 857091-32-8) should be stored in a tightly sealed container at room temperature (15-30°C), protected from light and moisture. It should be kept out of reach of children and away from incompatible materials.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Email

chenling@zzstandard.com